Skip to the content

FDA Medical Device Recalls (openFDA)

Becton Dickinson & Co.: BD MAX Enteric Bacterial Panel -For In Vitro Diagnostic Use with the BD MAX System Catalog Number: 442963 The BD MAX Enteric Bacterial Panel performed on the BD MAX System is an automated in vitro diagnostic test for the direct qualitative detection and differentiation of enteric bacterial pathogens.

Recall number
Z-0981-2019
Recalling firm
Becton Dickinson & Co.
Product
BD MAX Enteric Bacterial Panel -For In Vitro Diagnostic Use with the BD MAX System Catalog Number: 442963 The BD MAX Enteric Bacterial Panel performed on the BD MAX System is an automated in vitro diagnostic test for the direct qualitative detection and differentiation of enteric bacterial pathogens.
Status
Terminated
Initiated
2019-01-14
Posted
not on file
Terminated
2020-04-03
Reason
False negative results with the BD MAX Extended Enteric Bacterial Panel when testing specifically for Enterotoxigenic Escherichia coli (ETEC) and Plesiomonas shigelloides targets of the BD MAX Extended Enteric Bacterial Panel assay.
Root cause
Nonconforming Material/Component
Action
BD Diagnostic Systems issued "URGENT MEDICAL DEVICE PRODUCT ADVISORY" Customer letters via UPS on January 14, 2019. The letters described the product, problem, and actions to take. The customers were instructed to do the following: 1. Complete the attached Customer Response Form and return to BD Regulatory Compliance at Email: BDRC3@bd.com or Fax to: No.: 410-316-4258 whether or not you have any of the impacted material so that BD may acknowledge your receipt of this notification. 2. Although prevalence rates are considered to be low, if no other cause of enteric infection is determined you may choose to confirm any negative result for Enterotoxigenic Escherichia coli (ETEC) and Plesiomonas shigelloides obtained using the BD MAX Extended Enteric Bacterial Panel assay using an alternate method or using sample buffer tubes from a lot of EBP not listed above. Note that treatment for these infections is mainly supportive and antibiotics are not commonly used except in severe cases. 3. If your laboratory uses the xEBP assay and you would like replacement of your EBP kit(s), please complete the acknowledgement form included in the letter and return it via the instructions on the form. 4. Share this Advisory Letter with all users of the BD MAX instrument within your facility to ensure awareness. BD will provide replacement upon request using the Customer Response form. If you require further assistance, please contact: BD Customer/Technical Support 800-638-8663 Monday Friday between 7:00am and 7:00pm (EST) in the United States.
Quantity
1583 assay kits
Distribution
Worldwide Distribution: US (nationwide) to states of:CA, GA, HI, ID, MI, MN, MT, NJ, NM, OH, OR, PA, SC, TX, VA, VT, WA ; and to countries of: Australia, New Zealand, Canada, Europe, and Korea.
Lot, serial or model codes
Lot number/UDI 8194784 (01)00382904429638 (17)200222(10)8194784(30)1 and  8199682 (01)00382904429638 (17)200222(10)8199682(30)1 Expiration Date: 2020-02-22
510(k) numbers
["K140111"]
PMA numbers
not on file
Product code
PIC
Firm FEI
1119779
Firm city
Sparks
Firm state
MD
Firm country
not on file

Where this comes from

Register
FDA Medical Device Recalls (openFDA)
Publisher
U.S. Food and Drug Administration (openFDA)
File
device-recall-0001-of-0001.json.zip
sha256
b87518bfe2e8
Size
288210821 bytes
Published
2026-09-28
Read
2026-09-29T08:25:23.626Z
Source file
Source file retained · verify
Refresh due
2026-10-06

Unless otherwise noted, the content, data, documentation, code, and related materials on openFDA is public domain and made available with a Creative Commons CC0 1.0 Universal dedication.

Cite as

FDA Medical Device Recalls (openFDA) (U.S. Food and Drug Administration (openFDA)), device-recall-0001-of-0001.json.zip, sha256 b87518bfe2e8, published 2026-09-28

Search this register